Resources

  • References


    Ashwal S, Russman BS, Blasco PA, et al. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Neurology
    .
    2004;62(6):851-863.


    Cerebral palsy. EBSCO DynaMed website. Available at:
    https://dynamed.ebscohost.com/about/about-us
    . Updated December 14, 2012. Accessed February 1, 2013.


    Cerebral palsy (CP).
    Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities website. Available at:
    http://www.cdc.gov/ncbddd/cp/index.html
    .
    Updated September 7, 2012. Accessed February 1, 2013.


    Cerebral palsy: hope through research. National Institute of Neurological Disorders and Stroke website. Available at:
    http://www.ninds.nih.gov/disorders/cerebral%5Fpalsy/detail%5Fcerebral%5Fpalsy.htm
    . Updated August 23, 2012. Accessed February 1, 2013.


    Hazneci B, Tan AK, Guncikan MN, Dincer K, Kalyon TA.
    Comparison of the efficacies of botulinum toxin A and Johnstone pressure splints against hip adductor spasticity among patients with cerebral palsy: a randomized trial.
    Mil Med
    .
    2006;171(7):653-656.


    Johnson SL, Blair E, Stanley FJ. Obstetric malpractice litigation and cerebral palsy in term infants.
    J Forensic Leg Med
    . 2011;18(3):97-100.


    Nolan KW, Cole LL, Liptak GS. Use of botulinum toxin type A in children with cerebral palsy.
    Phys Ther
    .
    2006;86(4):573-584.


    Park ES, Park CI, Chang HC, Park CW, Lee DS.
    The effect of botulinum toxin type A injection into the gastrocnemius muscle on sit-to-stand transfer in children with spastic diplegic cerebral palsy.
    Clin Rehabil
    .
    2006;20(8):668-674.


    Steinbok P. Selection of treatment modalities in children with spastic cerebral palsy.
    Neurosurg Focus
    .
    2006;21(2):e4.


    10/30/2009 DynaMed's Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us
    : Mergler S, Evenhuis HM, Boot AM, et al. Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review.
    Dev Med Child Neurol
    .
    2009;51(10):773-778.


    2/4/2010 DynaMed's Systematic Literature Surveillance
    DynaMed's Systematic Literature Surveillance
    : Delgado MR, Hirtz D, Aisen M, et al. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Neurology
    .
    2010;74:336-343.


    7/30/2010 DynaMed's Systematic Literature Surveillance
    DynaMed's Systematic Literature Surveillance
    : United States Food and Drug Administration. FDA approves drug for chronic drooling in children. United States Food and Drug Administration website. Available at:
    http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm220444.htm
    .
    Published July 28, 2010. Accessed July 30, 2010.

  • Resources

    United Cerebral Palsy

    http://www.ucp.org

  • Canadian Resources

    The Cerebral Palsy Association of BC

    http://www.bccerebralpalsy.ca

    Ontario Federation for Cerebral Palsy

    http://www.ofcp.ca